OAR 855-115-0350: Services: Prescribing Practices - Short-acting Opioid Antagonists

(1) A Pharmacist may prescribe any FDA approved short-acting opioid antagonist (e.g., naloxone, nalmefene) and the necessary medical supplies to administer a short-acting opioid antagonist for opiate overdose: (a) When dispensing any opiate or opioid prescription in excess of 50 morphine milligram equivalents (MME); (b) To an individual seeking a short-acting opioid antagonist; (c) To an entity seeking a short-acting opioid antagonist. (2) A Pharmacist is not required to label the prescription according to OAR 855-041-1130 if dispensing a FDA approved short-acting opioid antagonist in the form of a nasal spray. (3) The Pharmacist must document the encounter, the prescription and maintain records according to OAR 855-104-0055.